4) New Chamath Biotech SPACs

[MP3Mike]

Chamath Palihapitiya created 4 new SPACs that started trading today. Each of the new SPACs will focus on a different area of biotech:

• Social Capital Suvretta Holdings Corp. I, DNAA, will focus on neurology
• Social Capital Suvretta Holdings Corp. II, DNAB, will target oncology
• Social Capital Suvretta Holdings Corp. III, DNAC, will begin with a focus on “the organ space subsector”
• Social Capital Suvretta Holdings Corp. IV, DNAD, will look for a merger in the immunology sector

It will be interesting to see what targets get chosen for each of them.

 

[Buckminster]

Chamath Palihapitiya created 4 new SPACs that started trading today. Each of the new SPACs will focus on a different area of biotech:

• Social Capital Suvretta Holdings Corp. I, DNAA, will focus on neurology
• Social Capital Suvretta Holdings Corp. II, DNAB, will target oncology
• Social Capital Suvretta Holdings Corp. III, DNAC, will begin with a focus on “the organ space subsector”
• Social Capital Suvretta Holdings Corp. IV, DNAD, will look for a merger in the immunology sector

It will be interesting to see what targets get chosen for each of them.

Will they each buy/merge with several companies?

 

[CLK350]

I did like Chamath and bought /traded some of his early SPACS. But after the damning Hindenburg research came out about his Clover deal, I'm staying clear of his SPACs. Something clearly went wrong in his head, IMHO..